Upon MEG3 silencing, pathologic features such as myocardial hypertrophy, fibrosis, and diastolic dysfunction were relieved after 6 weeks in a mouse model of arterial spasm coarctation of the aorta [73]. Here, MEG3 is linked to cardiac hypertrophy.